Latest article
Ropes & Grey Provention Bio Securities Case Diabetes Drug teplizumab
Yenis V. Argueta Guevara of Ropes & Gray has filed for drug developer Protection Bio and its top executives in...
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Novo Nordisk A/S : Diabetes drug maker Novo Nordisk upbeat on gross sales for...
COPENHAGEN, February 3rd (Reuters). Diabetes drug maker Novo Nordisk released positive sales and earnings guidance for 2021 on Wednesday after releasing expected fourth...